Cargando…
Bringing a genomic perspective to the safety of drug treatment in oncology
This article describes the clinical relevance of toxicity of therapies administered to patients with cancer, putting the patient, rather than disease, at the center of the evaluation of safety of anti-cancer therapy. Hence, the implications of adverse events are described from the patient perspectiv...
Autor principal: | Innocenti, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373416/ https://www.ncbi.nlm.nih.gov/pubmed/28408974 http://dx.doi.org/10.12688/f1000research.10475.1 |
Ejemplares similares
-
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018) -
Bringing New PET Drugs to Clinical Practice - A Regulatory Perspective
por: Hung, Joseph C.
Publicado: (2013) -
Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?
por: Timon-David, Elise, et al.
Publicado: (2022) -
What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
por: Zhang-Yin, Jules Tianyu, et al.
Publicado: (2022) -
Bringing microbiome-drug interaction research into the clinic
por: Guthrie, Leah, et al.
Publicado: (2019)